Los puntos clave no están disponibles para este artículo en este momento.
The 5-year survival rate in esophageal cancer, although poor, has improved over the past decade. This review discusses the epidemiologic aspects, pathogenesis, prevention, and therapy of esophageal adenocarcinoma and squamous-cell carcinoma, focusing on recent advances.
Rustgi et al. (Wed,) studied this question.